Bryant M. Whiting

Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study

John F. Carlquist, Benjamin D. Horne, Joseph B. Muhlestein et al. · Journal of Thrombosis and Thrombolysis · 2006 · 215 citations

Medicine, Pharmacokinetics, Pharmacology +16

Toll–like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes

Matthew J. Kolek, John F. Carlquist, Joseph B. Muhlestein et al. · American Heart Journal · 2004 · 136 citations

Life Sciences, Cardiology, Genetics +15

An intronic mutation causes long QT syndrome

Li Zhang, G. Michael Vincent, Marco Baralle et al. · Journal of the American College of Cardiology · 2004 · 65 citations

Life Sciences, Genetics, Molecular Genetics +6

Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery disease

Bryant M. Whiting, Jeffrey L. Anderson, Joseph B. Muhlestein et al. · American Heart Journal · 2005 · 44 citations

Medicine, Cardiology, Genetics +14

Urine-Based Assays for the Detection of Bladder Cancer

Patrick Villicana, Bryant M. Whiting, Steve Goodison et al. · Biomarkers in Medicine · 2009 · 37 citations

Medicine, Oncology, Urology +17